APA

Langleben D., Barst R. J., Badesch D., Groves B. M., Tapson V. F., Murali S., Bourge R. C., Ettinger N., Shalit E., Clayton L. M., Jöbsis M. M., Blackburn S. D., Crow J. W., Stewart D. J. & Long W. (19990716). Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. : Circulation.

Chicago

Langleben D, Barst R J, Badesch D, Groves B M, Tapson V F, Murali S, Bourge R C, Ettinger N, Shalit E, Clayton L M, Jöbsis M M, Blackburn S D, Crow J W, Stewart D J and Long W. 19990716. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. : Circulation.

Harvard

Langleben D., Barst R. J., Badesch D., Groves B. M., Tapson V. F., Murali S., Bourge R. C., Ettinger N., Shalit E., Clayton L. M., Jöbsis M. M., Blackburn S. D., Crow J. W., Stewart D. J. and Long W. (19990716). Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. : Circulation.

MLA

Langleben D, Barst R J, Badesch D, Groves B M, Tapson V F, Murali S, Bourge R C, Ettinger N, Shalit E, Clayton L M, Jöbsis M M, Blackburn S D, Crow J W, Stewart D J and Long W. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. : Circulation. 19990716.